日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma

格洛菲单抗治疗复发/难治性非霍奇金淋巴瘤的药效学和分子相关性

Bröske, Ann-Marie E; Korfi, Koorosh; Belousov, Anton; Wilson, Sabine; Ooi, Chia-Huey; Bolen, Christopher R; Canamero, Marta; Alcaide, Enrique Gomez; James, Ian; Piccione, Emily C; Carlile, David J; Dimier, Natalie; Umaña, Pablo; Bacac, Marina; Weisser, Martin; Dickinson, Michael

Oncogenicity of the developmental transcription factor Sox9.

发育转录因子Sox9的致癌性

Matheu Ander, Collado Manuel, Wise Clare, Manterola Lorea, Cekaite Lina, Tye Angela J, Canamero Marta, Bujanda Luis, Schedl Andreas, Cheah Kathryn S E, Skotheim Rolf I, Lothe Ragnhild A, López de Munain Adolfo, Briscoe James, Serrano Manuel, Lovell-Badge Robin

Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels

由于肿瘤内药物浓度低,Plk1抑制剂BI 2536对肝细胞癌进展的疗效降低。

Haupenthal, Jörg; Bihrer, Verena; Korkusuz, Huedayi; Kollmar, Otto; Schmithals, Christian; Kriener, Susanne; Engels, Knut; Pleli, Thomas; Benz, Alexander; Canamero, Marta; Longerich, Thomas; Kronenberger, Bernd; Richter, Swantje; Waidmann, Oliver; Vogl, Thomas J; Zeuzem, Stefan; Piiper, Albrecht